Gender-Affirming Hormone Treatment and Metabolic Syndrome Among Transgender Veterans.

ABSTRACT:

Importance

Gender-affirming hormone treatment (GAHT) is a common therapy for transgender individuals to reduce gender dysphoria and improve quality of life. Clarifying the long-term effects of GAHT remains a priority in transgender health research.

Objective

To explore whether sex hormones (estradiol and testosterone) are associated with the development of metabolic syndrome in transgender veterans compared with cisgender veterans.

Design, setting, and participants

This retrospective, longitudinal cohort study used International Classification of Diseases, Ninth Revision and International Statistical Classification of Diseases and Related Health Problems, Tenth Revision diagnosis codes for gender dysphoria from the Veterans Health Administration national database to i

SUBMITTER: Hashemi L 

PROVIDER: S-EPMC11220566 | biostudies-literature | 2024 Jul

REPOSITORIES: biostudies-literature